PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
62.82
-0.51 (-0.81%)
At close: Mar 6, 2026, 4:00 PM EST
63.10
+0.28 (0.45%)
After-hours: Mar 6, 2026, 5:57 PM EST

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Translarna Revenue
235.30M321.07M
Translarna Revenue Growth
-26.71%-3.51%
Emflaza Revenue
146.36M207.22M
Emflaza Revenue Growth
-29.37%-18.77%
Sephience Revenue
111.15M-
Upstaza/Kebilidi Revenue
56.63M16.91M
Upstaza/Kebilidi Revenue Growth
234.81%-10.23%
All Other Products Revenue
37.26M36.95M
All Other Products Revenue Growth
0.86%17.30%
Net Product Revenue
586.70M582.15M
Net Product Revenue Growth
0.78%-8.78%
Collaboration and License Revenue
998.36M304.00K
Collaboration and License Revenue Growth
328306.91%-99.70%
Royalty Revenue
244.22M203.86M
Royalty Revenue Growth
19.80%20.73%
Translarna France Revenue
-98.63M18.81M
Translarna France Revenue Growth
--18.49%
Manufacturing Revenue
-1.66M
Manufacturing Revenue Growth
--78.39%
Revenue (Other)
-586.70M-582.15M
Revenue (Total)
1.73B806.78M
Revenue (Total) Growth
114.51%-13.97%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Collaboration and License Revenue
998.36M304.00K
Collaboration and License Revenue Growth
328306.91%-99.70%
Royalty Revenue
244.22M203.86M
Royalty Revenue Growth
19.80%20.73%
Translarna France Revenue
-98.63M18.81M
Translarna France Revenue Growth
--18.49%
Manufacturing Revenue
-1.66M
Manufacturing Revenue Growth
--78.39%
United States - Net Product Revenue
252.19M207.22M
United States - Net Product Revenue Growth
21.70%-18.77%
Russia - Net Product Revenue
100.45M105.38M
Russia - Net Product Revenue Growth
-4.68%22.57%
Brazil - Net Product Revenue
65.66M72.08M
Brazil - Net Product Revenue Growth
-8.91%22.99%
All Other Countries - Net Product Revenue
168.41M197.47M
All Other Countries - Net Product Revenue Growth
-14.72%-17.21%
Revenue (Total)
1.73B806.78M
Revenue (Total) Growth
114.51%-13.97%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue (US)
-413.04M
United States Revenue (US) Growth
--22.31%
Non-US Revenue
-393.74M
Non-US Revenue Growth
--3.06%
Revenue (Total)
1.73B806.78M
Revenue (Total) Growth
114.51%-13.97%
Updated Dec 31, 2025. Data Source: Fiscal.ai.